Federal regulators say shortages of Ozempic and Wegovy have been resolved, as supplies of popular diabetes and obesity ...

Tirzepatide is just as effective in reducing cardiovascular risk driven by central adiposity as that driven by general ...

Obesity affects over a third of Missouri's adults and children, with rural areas hit hardest. It's a complex issue linked to mental health and accessibility, not just personal choice.

A new generation of anti-obesity drugs aims for greater effectiveness, fewer side effects, and more convenience.

More than three dozen attorneys general are urging the FDA to take “decisive action” against counterfeit obesity drugs.

Prescriptions of obesity management drugs (OMDs) have increased, and these increasing trends are associated with online search trends.

For many Americans, day-to-day survival comes before diet and lifestyle considerations. Kale is off the table.

The number of U.S. adults with severe obesity increased from 2013 to 2023, according to a research letter published online ...

President Donald Trump and HHS Secretary Robert F. Kennedy Jr. said they will be studying the "threat" to children posed by antidepressants and obesity medications.

Following the resolution of Eli Lilly’s tirzepatide shortage in October, the FDA has officially declared an end to the supply ...

The FDA has removed semaglutide from its drug shortage list after the agency determined the current supply of the drug can ...

HHS Secretary Robert F. Kennedy Jr. is preparing to remove committee members who advise the government on vaccine approvals ...